Noted Candela Senior Scientist Speaks On Skin Cooling At Harvard Symposium
WAYLAND, Mass., Aug 22, 2000 (BW HealthWire) -- Candela Corporation (NASDAQ:
CLZR) reports that Senior Scientist Karl Pope was a key speaker at a panel
discussion on skin cooling at Harvard Medical School's Advanced Symposium,
"Controversies and Conversations in Cutaneous Laser Surgery," August 11-13,
2000, in Woodstock, VT.
Candela's Pope was chosen for the panel discussion because of his expertise in
cooling technology for cutaneous laser procedures, including Candela's
proprietary Dynamic Cooling Device(TM) (DCD(TM)). DCD is integrated into the
company's Vbeam(TM) pulsed dye laser for vascular applications and its
GentleLASE(R) Plus advanced alexandrite laser for hair removal applications.
Pope comments, "A number of approaches have been employed with respect to
cooling the skin during laser therapy, including methods based on gel, cold air,
contact cooling and cryogen cooling. Of these, only cryogen cooling can cool the
same amount of skin the same way every time without relying on the operator.
This makes a huge difference in terms of reproducibility, and the protective
effect is highly consistent over the course of an entire laser treatment.
"When skin cooling is put into practice, the effects have been dramatic. In my
experience, when cryogen is used with the Candela GentleLASE PLUS hair removal
laser, the fluence can be increased without a change in the epidermal reaction.
"Similarly, the treatment of port wine stains using pulsed dye lasers has
undergone a renaissance with the addition of cryogen cooling, necessitating the
development of new lasers that produce more energy. New systems like Candela's
Vbeam are now treating previously 'untreatable' lesions."
Karl Pope holds an MSE degree in Biomedical Engineering from the University of
Texas at Austin and a BA in Biology from the University of California at Santa
Cruz.
The advanced symposium was conducted for ACCME credit by Harvard Medical
School's Department of Continuing Education and was offered by Boston's
world-renowned Beth Israel Deaconess Medical Center. |
